NewAmsterdam Pharma Co N.V Capital Expenditures (CapEx) Growth & History (NAMS)
NewAmsterdam Pharma Co N.V's capital expenditures (capex) was $246,000 for fiscal 2025.
View full NewAmsterdam Pharma Co N.V company overviewNewAmsterdam Pharma Co N.V annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $246,000 | −$426,000 | −63.39% |
| 2024 | 2024-12-31 | $672,000 | $648,000 | +2700.00% |
| 2023 | 2023-12-31 | $24,000 | −$197,000 | −89.14% |
| 2022 | 2022-12-31 | $221,000 | $197,000 | +820.83% |
| 2021 | 2021-12-31 | $24,000 | — | — |
NewAmsterdam Pharma Co N.V quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $80,000 | −$8,000 | −9.09% |
| Q1 2026 | 2026-03-31 | $38,000 | $22,000 | +137.50% |
| Q4 2025 | 2025-12-31 | $100,000 | $97,000 | +3233.33% |
| Q3 2025 | 2025-09-30 | $42,000 | −$33,000 | −44.00% |
| Q2 2025 | 2025-06-30 | $88,000 | −$121,000 | −57.89% |
| Q1 2025 | 2025-03-31 | $16,000 | −$369,000 | −95.84% |
| Q4 2024 | 2024-12-31 | $3,000 | $0 | 0.00% |
| Q3 2024 | 2024-09-30 | $75,000 | $66,000 | +733.33% |
| Q2 2024 | 2024-06-30 | $209,000 | $204,000 | +4080.00% |
| Q1 2024 | 2024-03-31 | $385,000 | $378,000 | +5400.00% |
| Q4 2023 | 2023-12-31 | $3,000 | — | — |
| Q3 2023 | 2023-09-30 | $9,000 | — | — |
| Q2 2023 | 2023-06-30 | $5,000 | — | — |
| Q1 2023 | 2023-03-31 | $7,000 | — | — |
NewAmsterdam Pharma Co N.V capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, NewAmsterdam Pharma Co N.V's capital expenditures (capex) increased from $24,000 to $246,000, a change of $222,000. The latest reported quarter, Q2 2026, shows $80,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NewAmsterdam Pharma Co N.V source filings ↗